Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1076 | 1000 | 1152 | 1217 | 1552 | 2606 |
Fund Return | 7.61% | -0.05% | 15.2% | 6.76% | 9.19% | 10.05% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth Cl F CAD | 4.34B | 8.20 | 8.15 | 11.50 | ||
Renaissance International Eq CAD | 1.86B | 6.51 | 2.36 | 6.92 | ||
Renaissance International Eq Cl CAD | 1.86B | 7.09 | 3.70 | 8.38 | ||
Renaissance US Equity Income F CAD | 1.39B | 7.77 | 8.08 | 10.39 | ||
Renaissance US Eq Income F Pr CAD | 1.39B | 7.80 | 8.14 | 10.52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer Global Equity | 13.12B | 5.16 | 8.18 | 10.87 | ||
Capital Group Glbal Equity Fd D CAD | 13.25B | 14.51 | 3.57 | 10.80 | ||
Capital Group Glbal Equity Fd F CAD | 13.25B | 14.67 | 3.92 | 11.29 | ||
Capital Group Glbal Equity Fd A CAD | 13.25B | 14.15 | 2.78 | 10.07 | ||
Fidelity Global Innovators Class F | 12.38B | 31.81 | 13.88 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.41 | 988.4 | +0.45% | |
Microsoft | US5949181045 | 4.05 | 427.87 | +0.95% | |
Mastercard | US57636Q1040 | 3.09 | 449.25 | -0.12% | |
Taiwan Semiconductor | US8740391003 | 3.06 | 168.16 | +2.29% | |
Linde PLC | IE000S9YS762 | 3.01 | 401.800 | -0.64% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review